Skip to main content

Table 9 Adherence to therapy in premenopausal breast cancer patients treated with tamoxifen or toremifene

From: A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study

  Tamoxifen (n = 240) Toremifene (n = 212) p value
 Total 45 31 0.242
 Transfer to AIs after menopause 24 15 0.269
 Discontinuance or other therapy 21 16 0.542
 Cervical cyst 1 0  
 Uterine fibroids 1 0  
 Ostalgia 1 0  
 Skinrash 2 0  
 Endometrial hyperplasia 5 0  
 In order to be pregnancy 1 1  
 Diarrhea 1 0  
 To fear adverse effect 1 4  
 Economic reason 1 0  
 Transaminase step-up 1 2  
 Chinese traditional medicine 2 0  
 Discontinuance for unknow reasons 4 6  
 Hyper-menorrhea 0 2  
 Vaginal bleeding 0 1